This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LeMaitre Vascular, Inc. Schedules Fourth Quarter Results And Conference Call

BURLINGTON, Mass., Feb. 17, 2011 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its 2010 fourth quarter and full-year financial results on February 28, 2011, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00 PM ET. The call will be broadcast simultaneously over the internet.

Interested participants may listen to the live webcast at www.lemaitre.com/investor , or dial in at 866-202-3109 ( +1-617-213-8844 for international callers), using passcode 38744818. A replay of the call will be available at www.lemaitre.com/investor .

During the call, LeMaitre Vascular's senior management will provide an overview of the 2010 fourth quarter results, business highlights and company outlook.

About LeMaitre Vascular, Inc.

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. We sell vascular devices and implants to address the needs of our core customer, the vascular surgeon. Our principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.

CONTACT: LeMaitre Vascular, Inc.
         Investor Relations
         Aaron Grossman, +1-781-221-2266
         http://www.lemaitre.com
         http://www.lemaitre.com/investor

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs